IP Library Granted Patent US 8,133,515
Granted Patent B2
US 8,133,515 · App. 12/743,632 · Granted Mar 13, 2012

Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds

Assignee: University of Georgia Research Foundation, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,133,515
App. No.
12/743,632
Granted
Mar 13, 2012
Kind
B2
Abstract

1,3-Dipole-functional compounds (e.g., azide functional compounds) can be reacted with certain alkynes in a cyclization reaction to form heterocyclic compounds. Useful alkynes (e.g., strained, cyclic alkynes) and methods of making such alkynes are also disclosed. The reaction of 1,3-dipole-functional compounds with alkynes can be used for a wide variety of applications including the immobilization of biomolecules on a substrate.

Claims (59)

1. An alkyne of the formula:

wherein:

each R 1 is independently selected from the group consisting of hydrogen, halogen, hydroxy, alkoxy, nitrate, nitrite, sulfate, and a C1-C10 organic group;

each R 2 is independently selected from the group consisting of hydrogen, halogen, hydroxy, alkoxy, nitrate, nitrite, sulfate, and a C1-C10 organic group;

X represents C═O, C═N—OR 3 , C═N—NR 3 R 4 , CHOR 3 , or CHNHR 3 ; and

each R 3 and R 4 independently represents hydrogen or an organic group.

2. The alkyne of claim 1 wherein R 3 comprises a covalently bound organic dye.

3. The alkyne of claim 1 wherein X represents C═N—OR 3 and R 3 represents an organic group having the formula —(CH 2 ) a C(O)Y, wherein:

a is 1-3;

Y represents OH or NHR 5 ; and

R 5 represents hydrogen or a biotinylation product of a primary amine-containing organic group.

4. The alkyne of claim 3 wherein the biotinylation product is the biotinylation product of a primary amine-containing group of the formula —(CH 2 CH 2 O) b (CH 2 ) c -L d -(CH 2 CH 2 O) e (CH 2 ) f NH 2 and/or —(CD 2 CD 2 O) b (CD 2 ) c -L d -(CD 2 CD 2 O) e (CD 2 ) f NH 2 , wherein b=0 to 100; c=0 to 100; d=0 to 100; e=0 to 100; f=0 to 100; and L is an optional cleavable linker.

5. The alkyne of claim 4 wherein the cleavable linker, if present, is a disulfide.

6. The alkyne of claim 1 wherein X represents CHOR 3 and R 3 is selected from the group consisting of an alkyl group, an aryl group, an alkaryl group, and an aralkyl group.

7. The alkyne of claim 6 wherein R 3 represents —C(O)Z, wherein:

Z represents an alkyl group, OR 6 , or NHR 7 ;

R 6 and R 7 are each independently selected from the group consisting of an alkyl group, an aryl group, an alkaryl group, and an aralkyl group.

8. An alkyne of the formula:

wherein:

each R 1 is independently selected from the group consisting of hydrogen, halogen, hydroxy, alkoxy, nitrate, nitrite, sulfate, and a C1-C10 organic group;

each R 2 is independently selected from the group consisting of hydrogen, halogen, hydroxy, alkoxy, nitrate, nitrite, sulfate, and a C1-C10 organic group;

X represents CHOR 3 ;

R 3 represents —C(O)Z, wherein:

Z represents an alkyl group, OR 6 , or NHR 7 ;

R 6 is selected from the group consisting of an alkyl group, an aryl group, an alkaryl group, and an aralkyl group; and

R 7 is a biotinylation product of a primary amine-containing organic group.

9. The alkyne of claim 8 wherein the biotinylation product is the biotinylation product of a primary amine-containing group of the formula —(CH 2 CH 2 O) b (CH 2 ) c -L d -(CH 2 CH 2 O) e (CH 2 ) f NH 2 and/or —(CD 2 CD 2 O) b (CD 2 ) c -L d -(CD 2 CD 2 O) e (CD 2 ) f NH 2 , wherein b=0 to 100; c=0 to 100; d=0 to 100; e=0 to 100; f=0 to 100; and L is an optional cleavable linker.

10. The alkyne of claim 9 wherein the cleavable linker, if present, is a disulfide.

11. An alkyne of the formula:

wherein:

each R 1 is independently selected from the group consisting of hydrogen, halogen, hydroxy, alkoxy, nitrate, nitrite, sulfate, and a C1-C10 organic group;

each R 2 is independently selected from the group consisting of hydrogen, halogen, hydroxy, alkoxy, nitrate, nitrite, sulfate, and a C1-C10 organic group;

X represents C═O, C═N—OR 3 , C═N—NR 3 R 4 , CHOR 3 , or CHNHR 3 ;

R 3 represents a polymeric or a copolymeric group; and

R 4 represents hydrogen or an organic group.

12. The alkyne of claim 11 wherein the copolymeric group comprises a hydrophilic segment and a hydrophobic segment.

13. The alkyne of claim 11 wherein the copolymeric group comprises a fragment of the formula —[CH 2 CH 2 O] n [C(O)(CH 2 ) 5 O] m —H, wherein n=0 to 100 and m=0 to 100.

14. An alkyne of the formula:

15. An alkyne of the formula:

16. An alkyne of the formula:

17. An alkyne of the formula:

wherein R 3 represents hydrogen or an organic group.

18. A composition comprising a blend of:

an alkyne according to claim 11 ; and

a polymer or a copolymer.

19. The composition of claim 18 wherein the composition forms a copolymer micelle.

20. A method for controlling the delivery of drugs, the method comprising:

combining at least one 1,3-dipole-functional drug with a copolymer micelle according to claim 19 comprising an alkyne; and

allowing the at least one 1,3-dipole-functional drug and the copolymer micelle comprising the alkyne to react under conditions effective to form a heterocyclic compound.

21. A method of preparing a heterocyclic compound, the method comprising:

combining at least one 1,3-dipole-functional compound with at least one alkyne according to claim 1 ; and

allowing the at least one 1,3-dipole-functional compound and the at least one alkyne to react under conditions effective to form the heterocyclic compound.

22. A substrate having on the surface thereof an alkyne according to claim 1 .

23. A method of immobilizing a biomolecule on a substrate, the method comprising:

providing a substrate according claim 22 ;

contacting the substrate with a 1,3-dipole-functional biomolecule under conditions effective to form a heterocyclic compound.

24. A method for immobilizing a cell, the method comprising:

providing a substrate according to claim 22 ;

contacting the substrate with a cell comprising a 1,3-dipole-functional biomolecule under conditions effective to form a heterocyclic compound.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 26, 2018
From: UNIVERSITY OF GEORGIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045164/0254 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2010
From: BOONS, GEERT-JAN; GUO, JUN; NING, XINGHAI; WOLFERT, MARGARETHA
To: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
Reel/Frame 024512/0838 →
Continuity (5)
Provisional Application 61004021 · Nov 21, 2007
Provisional Application 61007674 · Dec 14, 2007
Provisional Application 61137061 · Jul 25, 2008
Related Publication 20100297250A1 · Nov 25, 2010
Related Publication 20120040011A9 · Feb 16, 2012